Philly Fed Stays Negative, but With Slight Uptick
The Federal Reserve Bank of Philadelphia has released its regional report on manufacturing conditions in February.
All Work
Jon C. Ogg
Top Analyst Upgrades and Downgrades: Amazon, Brocade, Garmin, IBM, Nabors, Peabody Energy, Red Hat, Shopify, Urban Outfitters and More
The top analyst upgrades, downgrades and initiations seen on Thursday, February 18, include Amazon, Brocade, Garmin, IBM, Nabors Industries, Peabody Energy, Red Hat, Shopify and Urban Outfitters.
Positive News in Industrial Production and Capacity Utilization
Most economic reports have been soft, but January readings on industrial production and capacity utilization actually look better than expected.
Why Warren Buffett Bought Kinder Morgan Over Other Infrastructure and MLPs
How are investors to react when they see that Warren Buffett is still making bets in the oil and gas sector at a time when the sector has cratered?
Producer Price Index Brings Minor Smell of Inflation
The Bureau of Labor Statistics report on the Producer Price Index for January is a measure of wholesale inflation based on final demand.
Fannie Mae Lowers Fed Rate Hike Expectations for 2016
Fannie Mae is now only predicting two Federal Reserve rate hikes on fed funds in 2016. Their prior forecast had been three hikes.
Top Analyst Upgrades and Downgrades: Cerner, Intel, Peabody Energy, Rackspace, Weyerhaeuser, Whole Foods and More
Top analyst upgrades, downgrades and initiations seen on Wednesday, February 17, include Cerner, Intel, Peabody Energy, Rackspace, Weyerhaeuser and Whole Foods.
Major Changes Seen in Warren Buffett and Berkshire Hathaway Stocks for 2016
Warren Buffett has now released the official equity holdings of Berkshire Hathaway Inc. (NYSE: BRK-A) as of December 31, 2016. That makes this the official Buffett stocks for 2016, but we would advise readers…
What to Make of Apple’s Huge Debt Offering
Apple is about to have a massive benchmark note and bond offering. Word has been out that the offering will be in excess of $10 billion.
Analysts Abandon Community Health Systems Bullish Case
Community Health Systems spooked investors badly enough that all hospital stocks were running in the red on Tuesday.
Many Tech Analysts Change Ratings and Targets in Upgrades and Downgrades
24/7 Wall St. could not help but notice how many estimates and price targets were lowered in the tech sector on Tuesday.
How Analysts See Micron Now After Its Analyst Day Meeting
Micron Technology recently hosted its Analyst Day meeting, and 24/7 Wall St. has seen many research reports come out on the DRAM/NAND leader.
Empire Manufacturing Shows Another Contraction in February
The New York Federal Reserve has released its Empire Manufacturing Survey for the month of February.
Top Analyst Upgrades and Downgrades: Broadcom, Dollar General, Goldman Sachs, Peabody Energy, Qualcomm, SunEdison and More
The top analyst upgrades, downgrades and initiations seen on Tuesday include Broadcom, Dollar General, Goldman Sachs, Peabody Energy, Qualcomm and SunEdison.
4 Oil and Gas Stocks Analysts Want You to Buy
Wall Street analysts still think some oil companies offer incredible long-term upside. Here are four oil and gas stocks with recent analyst upgrades or very positive calls.
Where Did All the TripAdvisor Bulls Go After Strong Earnings?
The caution in the stock market and more moderate growth rates seem to have played a role in taming some of the TripAdvisor bulls.
Big Changes Seen in FireEye Upside After Earnings and Guidance
What mattered more than FireEye's fourth-quarter earnings was its guidance and bookings, which created a much more cautious or modest valuation range from analysts.
How Analysts Are Changing Their 2016 Boeing Bull/Bear Case
So, the 2016 Boeing bullish and bearish outlook is not panning out at all the way things looked at the end of 2015 and the start of 2016.
8 Analyst Stocks Under $10 With Massive Upside Potential
There are many more caveats to consider, but here are eight analyst stock picks under $10.00 with massive upside potential, if the analyst assumptions in each prove to be correct.
6 Biotech and Pharma Stocks Analysts Want You to Buy Now
Here are six biotech and pharma stocks that analysts are telling their firm's clients to buy now for solid upside opportunities ahead.